THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 25 filers reported holding THERAVANCE INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,205,273,000 | +223.3% | 8,326,000 | +228.3% | 0.01% | +225.0% |
| Q1 2021 | $2,537,598,000 | +207.4% | 2,536,000 | +205.5% | 0.00% | +100.0% |
| Q4 2020 | $825,535,000 | +3.9% | 830,000 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $794,368,000 | -90.2% | 830,000 | -89.9% | 0.00% | -92.9% |
| Q2 2020 | $8,076,626,000 | +6.2% | 8,184,000 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $7,608,174,000 | +519.2% | 8,184,000 | +567.5% | 0.02% | +700.0% |
| Q4 2019 | $1,228,673,000 | +198.1% | 1,226,000 | +179.3% | 0.00% | +100.0% |
| Q3 2019 | $412,111,000 | -80.3% | 439,000 | -78.0% | 0.00% | -75.0% |
| Q2 2019 | $2,095,402,000 | +61.5% | 1,998,000 | +56.2% | 0.00% | +33.3% |
| Q1 2019 | $1,297,546,000 | +158.8% | 1,279,000 | +175.6% | 0.00% | +200.0% |
| Q4 2018 | $501,412,000 | +21.6% | 464,000 | +14.0% | 0.00% | 0.0% |
| Q3 2018 | $412,344,000 | +4.4% | 407,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $394,859,000 | – | 407,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |